March 22, 2022 – Hanger Clinic announced its proprietary AmpuShield® limb protector has received an Innovative Technology contract from Vizient, Inc., the nation’s largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of AmpuShield by hospital experts who serve on one of Vizient’s member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.
Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.
The AmpuShield is a post-amputation residual limb protector clinically proven to optimize patient outcomes and reduce the length of acute hospital stays through contracture prevention, wound protection, faster healing time, earlier ambulation, and reducing the risk of revision surgery due to falls. Wearing an adjustable, removable AmpuShield allows easier access and monitoring of the patient’s surgical site, reduces post-operative swelling, and helps patients heal and progress towards being fit with a prosthesis sooner.
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $110 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.